Vitamin C in Alternative Cancer Treatment: Historical Background
Open Access
- 1 June 2003
- journal article
- research article
- Published by SAGE Publications in Integrative Cancer Therapies
- Vol. 2 (2) , 147-154
- https://doi.org/10.1177/1534735403002002007
Abstract
Ascorbic acid is the single-nutrient supplement most commonly used by cancer patients, although in most cases this takes place without the physician's knowledge or supervision. A comprehensive review of the literature is presented on the impact of ascorbic acid on cancer survival. Findings from 6 uncontrolled studies suggest that ascorbic acid may increase survival, whereas 2 controlled trials have yielded null results. The relative strengths and limitations of these studies are discussed. A turning point occurred with the release of the 2 controlled (null) studies, which influenced many physicians to turn away from nutrition in the care of cancer patients. Controversy about these trials still persists, however, in the alternative cancer community.Keywords
This publication has 25 references indexed in Scilit:
- A Proposition: Megadoses of Vitamin C are Valuable in the Treatment of CancerNutrition Reviews, 2009
- Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physiciansSupportive Care in Cancer, 2002
- Types of Alternative Medicine Used by Patients with Breast, Colon, or Prostate Cancer: Predictors, Motives, and CostsThe Journal of Alternative and Complementary Medicine, 2002
- Frequency of Use of Complementary and Alternative Medicine in Women With Breast CancerOncology Nursing Forum, 2002
- Vitamin C Intake and Mortality among a Sample of the United States PopulationEpidemiology, 1992
- Vitamin C: The nontoxic, nonrate-limited, antioxidant free radical scavengerMedical Hypotheses, 1985
- Evidence of rebound effect with ascorbic acidMedical Hypotheses, 1984
- Vitamin C Therapy of Advanced CancerNew England Journal of Medicine, 1980
- Failure of High-Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients with Advanced CancerNew England Journal of Medicine, 1979
- The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancerChemico-Biological Interactions, 1974